dog |
LD |
intraperitoneal |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |
dog |
LD |
oral |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |
dog |
LD |
subcutaneous |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |
mouse |
LD |
intraperitoneal |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |
mouse |
LD |
oral |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |
mouse |
LD |
subcutaneous |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |
mouse |
LD50 |
intravenous |
440mg/kg (440mg/kg) |
? |
Toxicology and Applied Pharmacology. Vol. 24, Pg. 497, 1973. |
rat |
LD |
intraperitoneal |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |
rat |
LD |
oral |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |
rat |
LD |
subcutaneous |
> 5gm/kg (5000mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 416, 1992. |